ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia

Biernacki MA., et al.
JCI
Journal of Clinical Investigation
September 2020
Authors and Affiliates
Melinda A Biernacki 1,2, Kimberly A Foster 1, Kyle B Woodward 1, Michael E Coon 1, Carrie Cummings 1, Tanya M Cunningham 1, Robson G Dossa 1, Michelle Brault 1, Jamie Stokke 1,3, Tayla M Olsen 1, Kelda Gardner 2, Elihu Estey 1,2, Soheil Meshinchi 1,3, Anthony Rongvaux 1,4, Marie Bleakley 1,3; 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. 2 Department of Medicine. 3 Department of Pediatrics, and. 4 Department of Immunology, University of Washington, Seattle, Washington, USA.